Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

GINKGO BIOWORKS HOLDINGS INC (DNA)

182 + Investors. Track Smart Money conviction in DNA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
2Q ▲
Buyers last Q
54%

Smart Money Signals — DNA

Based on 170 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added DNA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 54% of 3.0Y high

54% of all-time peak
Only 170 funds hold DNA today versus a peak of 316 funds at 2023 Q3 — just 54% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+11 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

86 buying73 selling
Last quarter: 86 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~31 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 25 → 34 → 32 → 31. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

63% of holders stayed for 2+ years

■ 63% conviction (2yr+) ■ 19% medium ■ 18% new
107 out of 170 hedge funds have held DNA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +7%, value -62%

Value
-61%
Shares
+6%
Last quarter: funds added +7% more shares while total portfolio value only changed -62%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~31 new funds/quarter

33 → 25 → 34 → 32 → 31 new funds/Q
New funds entering each quarter: 25 → 34 → 32 → 31. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 73% of holders stayed 2+ years

■ 73% veterans ■ 10% 1-2yr ■ 18% new
Of 182 current holders: 132 (73%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
32 of 170 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in DNA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
1.3
out of 10
Low Exit Risk
Exit risk score 1.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: DNA

How many hedge funds hold DNA — quarterly history vs. share price
Quarterly hedge fund ownership of DNA vs. share price

Market Analysis: DNA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DNA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

28 top-rated funds 0 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
0.4
/ 10
conviction
Hedge Fund Positioning: DNA
2026 Q1 Stats Unlock in 11 days 182 + Investors

Track Smart Money conviction in DNA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 182 179 1.68%
13F Shares 33M 31M 6.59%
Total Value $298M $780M -61.79%
New Positions 34 35 -1
Increased Positions 62 59 +3
Closed Positions 32 21 +11
Reduced Positions 55 46 +9
Total Calls 9 9 -
Total Puts 5 6 -16.67%
PUT/CALL Ratio 0.56 0.67 Bullish

Statistics: DNA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

182 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DNA. Verified SEC 13F-HR filings.

Top 25 institutional holders of DNA — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 FORBES J M & CO LLP 0.53% 1,028,391 $6.3M
2 PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 0.33% 541,845 $3.3M
3 Green Alpha Advisors, LLC 0.08% 13,776 $84K
4 ALLEN OPERATIONS LLC 0.06% 61,951 $380K
5 Inspire Investing, LLC 0.04% 83,905 $514K
6 FNY Investment Advisers, LLC 0.04% 15,380 —
7 AlphaQuest LLC 0.02% 37,279 $310K
8 Boston Standard Wealth Management, LLC 0.02% 15,165 $97K
9 BAILLIE GIFFORD & CO 0.01% 2,391,649 $14.7M
10 EXCHANGE TRADED CONCEPTS, LLC 0.01% 321,962 $2.0M
11 WELCH & FORBES LLC 0.00% 30,000 $184K
12 Legal & General Group Plc 0.00% 1,661,587 $10.2M
13 Cornerstone Planning Group LLC 0.00% 1,500 $15K
14 VSM Wealth Advisory, LLC 0.00% 1,000 $6K
15 Modera Wealth Management, LLC 0.00% 21,828 $134K
16 Capital Advisors, Ltd. LLC 0.00% 1,269 —
17 INTECH INVESTMENT MANAGEMENT LLC 0.00% 12,306 $75K
18 SBI Securities Co., Ltd. 0.00% 3,890 $24K
19 UBS Group AG 0.00% 582,799 $3.6M
20 Police & Firemen's Retirement System of New Jersey 0.00% 10,170 $62K
21 VANGUARD FIDUCIARY TRUST CO 0.00% 274,739 $1.7M
22 Legacy Wealth Managment, LLC/ID 0.00% 112 —
23 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 1,914,428 $11.7M
24 GAMMA Investing LLC 0.00% 835 $5K
25 Swiss National Bank 0.00% 65,063 $399K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — GINKGO BIOWORKS HOLDINGS INC (DNA)

What does the Smart Money Trend signal show for DNA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added DNA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DNA?

Slight buying edge — 54% buying: Last quarter: 86 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for DNA holders?

Elite ownership — 40% AUM from top-100 funds: 32 of 170 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in DNA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held DNA?

63% of holders stayed for 2+ years: 107 out of 170 hedge funds have held DNA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.